Polaris Enrolls First Patient In Phase 2 Clinical Trial Of ADI-PEG 20 For The Treatment Of Malignant Mesothelioma
Links shared publicly online about this topic.
- 426total visits
Polaris Enrolls First Patient In Phase 2 Clinical Trial Of ADI-PEG 20 For The Treatment Of Malignant Mesothelioma
Polaris Group announced the enrollment of the first patient in a Phase 2 clinical trial of ADI-PEG 20 (pegylated arginine deiminase), the company's novel enzyme-based treatment for malignant mesot
View full resource at medicalnewstoday.com
Tags: Cancer, Phase 2 Clinical Trial, Clinical Trial
Most Recently Shared on March 20, 2011 at 12:26 pm By:
Polaris Enrolls First Patient In Phase 2 Clinical Trial Of ADI-PEG 20 For The Treatment Of Malignant Mesothelioma http://ow.ly/1bQEdg
Also Shared By:
Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma
news-medical.net — “Polaris Group announced today the enrollment of the first patient in a Phase 2 clinical trial of ADI-PEG 20, the company's novel enzyme-based treatment for malignant mesothelioma.” View full resource at news-medical.net
Most Recently Shared on March 19, 2011 at 7:03 am By:
Lung Cancer News: Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma: Polaris Gr... http://bit.ly/hAbSUQ
Advertisement
MNT Cancer News
@mnt_cancer
Polaris Enrolls First Patient In Phase 2 Clinical Trial Of ADI-PEG 20 For The Treatment Of Malignant Mesothelioma http://mnt.to/3Svp #cancer
1 year ago...